Calcium signaling and neurodegenerative diseases

Research output: Contribution to journalArticle

248 Citations (Scopus)

Abstract

Neurodegenerative disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD) and spinocerebellar ataxias (SCAs), present an enormous medical, social, financial and scientific problem. Recent evidence indicates that neuronal calcium (Ca2+) signaling is abnormal in many of these disorders. Similar, but less severe, changes in neuronal Ca2+ signaling occur as a result of the normal aging process. The role of aberrant neuronal Ca2+ signaling in the pathogenesis of neurodegenerative disorders is discussed here. The potential utility of Ca2+ blockers for treatment of these disorders is also highlighted. It is reasoned that Ca2+ blockers will be most beneficial clinically when used in combination with other disease-specific therapeutic approaches.

Original languageEnglish (US)
Pages (from-to)89-100
Number of pages12
JournalTrends in Molecular Medicine
Volume15
Issue number3
DOIs
StatePublished - Mar 2009

Fingerprint

Calcium Signaling
Neurodegenerative Diseases
Spinocerebellar Ataxias
Huntington Disease
Amyotrophic Lateral Sclerosis
Parkinson Disease
Alzheimer Disease
Therapeutics

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine

Cite this

Calcium signaling and neurodegenerative diseases. / Bezprozvanny, Ilya.

In: Trends in Molecular Medicine, Vol. 15, No. 3, 03.2009, p. 89-100.

Research output: Contribution to journalArticle

@article{5bfe52c5933b4254a9db6143e9c0ba06,
title = "Calcium signaling and neurodegenerative diseases",
abstract = "Neurodegenerative disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD) and spinocerebellar ataxias (SCAs), present an enormous medical, social, financial and scientific problem. Recent evidence indicates that neuronal calcium (Ca2+) signaling is abnormal in many of these disorders. Similar, but less severe, changes in neuronal Ca2+ signaling occur as a result of the normal aging process. The role of aberrant neuronal Ca2+ signaling in the pathogenesis of neurodegenerative disorders is discussed here. The potential utility of Ca2+ blockers for treatment of these disorders is also highlighted. It is reasoned that Ca2+ blockers will be most beneficial clinically when used in combination with other disease-specific therapeutic approaches.",
author = "Ilya Bezprozvanny",
year = "2009",
month = "3",
doi = "10.1016/j.molmed.2009.01.001",
language = "English (US)",
volume = "15",
pages = "89--100",
journal = "Trends in Molecular Medicine",
issn = "1471-4914",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Calcium signaling and neurodegenerative diseases

AU - Bezprozvanny, Ilya

PY - 2009/3

Y1 - 2009/3

N2 - Neurodegenerative disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD) and spinocerebellar ataxias (SCAs), present an enormous medical, social, financial and scientific problem. Recent evidence indicates that neuronal calcium (Ca2+) signaling is abnormal in many of these disorders. Similar, but less severe, changes in neuronal Ca2+ signaling occur as a result of the normal aging process. The role of aberrant neuronal Ca2+ signaling in the pathogenesis of neurodegenerative disorders is discussed here. The potential utility of Ca2+ blockers for treatment of these disorders is also highlighted. It is reasoned that Ca2+ blockers will be most beneficial clinically when used in combination with other disease-specific therapeutic approaches.

AB - Neurodegenerative disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD) and spinocerebellar ataxias (SCAs), present an enormous medical, social, financial and scientific problem. Recent evidence indicates that neuronal calcium (Ca2+) signaling is abnormal in many of these disorders. Similar, but less severe, changes in neuronal Ca2+ signaling occur as a result of the normal aging process. The role of aberrant neuronal Ca2+ signaling in the pathogenesis of neurodegenerative disorders is discussed here. The potential utility of Ca2+ blockers for treatment of these disorders is also highlighted. It is reasoned that Ca2+ blockers will be most beneficial clinically when used in combination with other disease-specific therapeutic approaches.

UR - http://www.scopus.com/inward/record.url?scp=61849142791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61849142791&partnerID=8YFLogxK

U2 - 10.1016/j.molmed.2009.01.001

DO - 10.1016/j.molmed.2009.01.001

M3 - Article

VL - 15

SP - 89

EP - 100

JO - Trends in Molecular Medicine

JF - Trends in Molecular Medicine

SN - 1471-4914

IS - 3

ER -